Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | POLB | P06746 | 3/20 | 0.33 |
| ▸ | BAZ1A | Q9NRL2 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | NLRP1 | Q9C000 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.32 |
| ▸ | GAA | P10253 | 2/20 | 0.32 |
| ▸ | RECQL | P46063 | 2/20 | 0.32 |
| ▸ | BLM | P54132 | 2/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4461476 | 0.85 | RXFP1 (0.42) | LMNARXFP1TDP1ALDH1A1POLB | |
| SCHEMBL21303921 | 0.85 | LMNA (0.32) | LMNARXFP1TDP1 | |
| SCHEMBL3298153 | 0.79 | POLB (0.52) | LMNAALDH1A1POLBCYP1A2GAA | |
| SCHEMBL24313998 | 0.78 | RXFP1 (0.38) | LMNARXFP1TDP1ALDH1A1POLB | |
| SCHEMBL5052723 | 0.77 | CYP1A2 (0.40) | CYP1A2 | |
| SCHEMBL13554533 | 0.74 | POLB (0.52) | LMNAALDH1A1POLBHPGDCYP1A2 | |
| Methacrylic Acid SCHEMBL195249 | 0.73 | LMNA (0.54) | LMNATDP1ALDH1A1POLBHPGD | |
| SCHEMBL5916292 | 0.73 | TDP1 (0.63) | LMNATDP1ALDH1A1HPGDCYP1A2 | |
| Methacrylic Acid SCHEMBL23358775 | 0.73 | LMNA (0.54) | LMNATDP1ALDH1A1POLBHPGD | |
| SCHEMBL21303918 | 0.73 | RXFP1 (0.35) | LMNARXFP1TDP1ALDH1A1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180105618-A1 | N-HALAMINE MELAMINE DERIVATIVES AS NOVEL DECONTAMINATION AND BIOCIDAL AGENTS | STATE OF ISRAEL PRIME MINISTER'S OFFICE ISRAEL INSTITUTE FOR BIOLOGICAL RESEARCH (IL) | 2018-04-19 | — | — | US | disclosed |
| US-20180105618-A1 | N-HALAMINE MELAMINE DERIVATIVES AS NOVEL DECONTAMINATION AND BIOCIDAL AGENTS | STATE OF ISRAEL PRIME MINISTER'S OFFICE ISRAEL INSTITUTE FOR BIOLOGICAL RESEARCH (IL) | 2018-04-19 | — | — | US | disclosed |
| US-7024084-B2 | Electrodeposition solution, optical part produced therefrom, and production method for same optical part | FUJI XEROX CO., LTD. (JP) | 2006-04-04 | — | — | US | disclosed |
| US-6797531-B2 | Process for producing microlens array, array master, electrolytic solution and microlens array resin material therefor and apparatus for producing master | FUJI XEROX CO., LTD. (JP) | 2004-09-28 | — | — | US | disclosed |
| US-20040057688-A1 | Electrodeposition solution, optical part produced therefrom, and production method for same optical part | FUJI XEROX CO., LTD. (JP) | 2004-03-25 | — | — | US | disclosed |
| US-6707612-B2 | RADIATING WITH LIGHT REGION OF PHOTO-SEMICONDUCTOR THIN FILM TO APPLY VOLTAGE BETWEEN COUNTERELECTRODE; PRECIPITATION | FUJI XEROX CO., LTD. (JP) | 2004-03-16 | — | — | US | disclosed |
| US-20040001259-A1 | Process for producing microlens array, array master, electrolytic solution and microlens array resin material therefor and apparatus for producing master | FUJI XEROX CO., LTD. (JP) | 2004-01-01 | — | — | US | disclosed |
| US-20030142409-A1 | Method of manufacturing micro-lens array, electrolyte and manufacturing apparatus used therefor | FUJI XEROX CO., LTD. (JP) | 2003-07-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180105618-A1 | N-HALAMINE MELAMINE DERIVATIVES AS NOVEL DECONTAMINATION AND BIOCIDAL AGENTS | HNMT, CAT, TYR | LMNA 1687/4885RXFP1 4750/4885TDP1 2172/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.